24th International AIDS Conference (AIDS 2022): Final report
1 December 2022. Related: Conference reports.
World AIDS 24 Montreal 2022
IAS 2022: Metabolic complications of newer HIV drugs in older people
1 December 2022. Related: Conference reports, Lipodystrophy and metabolic complications.
24th International AIDS Conference (AIDS 2022): further reports
3 October 2022. Related: Conference reports.
AIDS 2022: Efficacy of DTG- vs EFV-based first-line ART in advanced HIV with CD4 <50 cells/mm3
3 October 2022. Related: Conference reports, Antiretrovirals, Treatment strategies.
AIDS 2022: Gender-affirming hormones, weight gain and ART
3 October 2022. Related: Conference reports, PK and drug interactions, Side effects.
24th International AIDS Conference (AIDS 2022)
1 September 2022. Related: Conference reports.
Dolutegravir no longer linked to higher risk of neural tube defects: latest update from the Tsepamo study
1 September 2022. Related: Conference reports, Pregnancy.
Weight gain with dolutegravir and TAF in ADVANCE study continues out to week 192
1 September 2022. Related: Conference reports, Women's health.
VRC01 added to early ART in infants did not reduce viral reservoir
1 September 2022. Related: Conference reports, Paediatric care.
Using PrEP during pregnancy is safe for children
1 September 2022. Related: Conference reports, Pregnancy, Paediatric care.
Long-acting CAB/RPV injections have a similar weight and lipid profile to dolutegravir-based oral ART
1 September 2022. Related: Conference reports.
Montreal’s response to monkeypox: rapid vaccine rollout, 39 breakthrough infections
1 September 2022. Related: Conference reports, mpox (monkeypox).
Summary of 620 cases of monkeypox seen at three London clinics
1 September 2022. Related: Conference reports, mpox (monkeypox).
Advances in HIV cure-related research: IAS workshop now online
1 September 2022. Related: Conference reports.
24th International AIDS Conference (AIDS 2022): first reports
3 August 2022. Related: Conference reports.
Dolutegravir-based ART in children and adolescents: effective in six African countries
3 August 2022. Related: Conference reports, Antiretrovirals, Treatment strategies, Paediatric care.
Early data on injecting CAB/RPV-LA into thigh muscle
3 August 2022. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Doxycycline PEP significantly reduces STIs in people at high risk of infections
3 August 2022. Related: Conference reports, Coinfections and complications.
Another possible HIV cure case after stem cell transplantation for cancer; example of extended post-treatment control in Spain
3 August 2022. Related: Conference reports, Cure-related research.
Other cure-related sessions at AIDS 2022
3 August 2022. Related: Conference reports, Cure-related research.
Selected reports launched at AIDS 2022
3 August 2022. Related: Conference reports, On the web.